Literature DB >> 19337279

Therapy: are TNF inhibitors safe in pregnancy?

Monika Østensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19337279     DOI： 10.1038/nrrheum.2009.47

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register.

Authors:  Kimme L Hyrich; Deborah P M Symmons; Kath D Watson; Alan J Silman
Journal:  Arthritis Rheum       Date:  2006-08

2.  Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum.

Authors:  M Østensen; F Förger; J L Nelson; A Schuhmacher; G Hebisch; P M Villiger
Journal:  Ann Rheum Dis       Date:  2004-11-11       Impact factor: 19.103

Review 3.  VATER non-random association of congenital malformations: study based on data from four malformation registers.

Authors:  K Källén; P Mastroiacovo; E E Castilla; E Robert; B Källén
Journal:  Am J Med Genet       Date:  2001-06-01

4.  Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.

Authors:  Jeffry A Katz; Christian Antoni; Gregory F Keenan; Deirdre E Smith; Stephen J Jacobs; Gary R Lichtenstein
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

5.  Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship.

Authors:  John D Carter; Joanne Valeriano; Frank B Vasey
Journal:  J Rheumatol       Date:  2006-05       Impact factor: 4.666

6.  Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature.

Authors:  Jean-Marie Berthelot; Michel De Bandt; Philippe Goupille; Elisabeth Solau-Gervais; Frédéric Lioté; Vincent Goeb; Isabelle Azaïs; Antoine Martin; Béatrice Pallot-Prades; Yves Maugars; Xavier Mariette
Journal:  Joint Bone Spine       Date:  2008-12-06       Impact factor: 4.929

7.  Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion.

Authors:  Edward E Winger; Jane L Reed
Journal:  Am J Reprod Immunol       Date:  2008-04-01       Impact factor: 3.886

8.  A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.

Authors:  John D Carter; Anil Ladhani; Louis R Ricca; Joanne Valeriano; Frank B Vasey
Journal:  J Rheumatol       Date:  2009-03       Impact factor: 4.666

Review 9.  Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data.

Authors:  Christina D Chambers; Zuhre N Tutuncu; Diana Johnson; Kenneth L Jones
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156
  9 in total
  2 in total

Review 1.  The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy.

Authors:  May Ching Soh; Marcelo Moretto
Journal:  Obstet Med       Date:  2019-05-30

Review 2.  Management of RA medications in pregnant patients.

Authors:  Monika Østensen; Frauke Förger
Journal:  Nat Rev Rheumatol       Date:  2009-06-09       Impact factor: 20.543
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.